Medical marijuana

Showing 7 posts of 7 posts found.


Medical cannabis: A green light for patients in need?

April 15, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Insider Interview, Medical marijuana, cannabis, feature, pharma

Spinnaker Opportunities announced in February it had reached a preliminary agreement to acquire cannabis oil-focused research firm Kanabo Research and …


Scientists genetically modify yeast to produce CBD and THC

February 28, 2019
Research and Development Medical marijuana, berkely, cannabis, science, yeast

Researchers at the University of California, Berkeley have genetically modified brewer’s yeast so that it produces two common cannabinoids: tetrahydrocannabinol …


Australian firm Althea enters UK medicinal cannabis market

February 13, 2019
Research and Development Epidiolex, GW Pharma, Medical marijuana, NHS, UK, cannabis

Melbourne-based medicinal cannabis company Althea has become one of the first companies to enter the UK market after the British …


GW Pharma’s Epidiolex becomes first cannabis-based medicine to be made available in United States

November 2, 2018
Medical Communications Epidiolex, GW Pharma, Medical marijuana, cannabidiol, cannabis

GW Pharma’s Epidiolex has become the first plant-derived, cannabis-based medicine to be made available on prescription in all 50 US …


Medical Marijuana to be legalised in Thailand and Malaysia as drug becomes available on prescription in UK

November 1, 2018
Business Services, Medical Communications Medical marijuana, UK, cannabis, malaysia, thailand

Thailand’s public health ministry is working to make medical marijuana legal by next month. The shift is expected to come …


Novartis steps into the medical marijuana business

March 20, 2018
Manufacturing and Production, Sales and Marketing Medical marijuana, Novartis, Sandoz, biotech, drugs, pharma, pharmaceutical

Canada’s burgeoning medical marijuana industry has finally drawn in a big pharma player. Tilray, a producer of medical cannabis products, …


GW Pharma releases positive data on cannabidiol-based Phase III trial

September 28, 2016
Research and Development Epidiolex, GW Pharmaceuticals, Marijuana, Medical marijuana, cannabis

GW Pharmaceuticals’ Epidiolex is designed to treat seizures in a rare form of epilepsy called Lennox-Gaustaut Syndrome. GW pharmaceuticals published …

Latest content